Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

CareDx, Inc (CDNA)

21.53   -1 (-4.44%) 08-18 07:26
Open: 22.1 Pre. Close: 22.53
High: 22.38 Low: 21.52
Volume: 489,823 Market Cap: 1,151(M)
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company also offers TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution; Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 22.39 - 22.54 22.54 - 22.66
Low: 21.24 - 21.38 21.38 - 21.5
Close: 21.32 - 21.55 21.55 - 21.75

Technical analysis

as of: 2022-08-17 4:22:08 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 29.32     One year: 31.92
Support: Support1: 21.52    Support2: 17.9
Resistance: Resistance1: 25.11    Resistance2: 27.32
Pivot: 24.02
Moving Average: MA(5): 23     MA(20): 23.99
MA(100): 26.6     MA(250): 40.44
MACD: MACD(12,26): -0.3     Signal(9): 0
Stochastic oscillator: %K(14,3): 19.7     %D(3): 28.3
RSI: RSI(14): 41.4
52-week: High: 81.44  Low: 19.34
Average Vol(K): 3-Month: 831 (K)  10-Days: 929 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ CDNA ] has closed below the lower bollinger band by 1.6%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ CDNA ] is to continue within current trading range. Bollinger Bands are 37% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 17 Aug 2022
Streptococcus suis TrpX is part of a tryptophan uptake system, and its expression is regulated by a T-box regulatory element | Scientific Reports - Nature.com

Tue, 16 Aug 2022
CareDx (NASDAQ:CDNA) PT Lowered to $37.00 at BTIG Research - MarketBeat

Thu, 11 Aug 2022
CareDx and MOTTEP Co-Host Health Equity Summit - Yahoo Finance

Tue, 09 Aug 2022
Comprehensive analysis of transglutaminase substrate preference by cDNA display coupled with next-generation sequencing and bioinformatics | Scientific Reports - Nature.com

Sun, 07 Aug 2022
CareDx, Inc. (CDNA) CEO Reg Seeto on Q2 2022 Results - Earnings Call Transcript - Seeking Alpha

Fri, 05 Aug 2022
Is CareDx Inc (CDNA) a Stock to Watch After Losing 0.00% This Week? - InvestorsObserver

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. 0 (M)
Shares Float 53 (M)
% Held by Insiders 5.288e+007 (%)
% Held by Institutions 1.9 (%)
Shares Short 3,600 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -5.394e+007
EPS Est Next Qtl -0.18
EPS Est This Year -0.82
EPS Est Next Year -0.34
Book Value (p.s.) 0
Profit Margin (%) -3
Operating Margin (%) -22.1
Return on Assets (ttm) -20.4
Return on Equity (ttm) -7.3
Qtrly Rev. Growth 3.1486e+008
Gross Profit (p.s.) 19.56
Sales Per Share -11.74
EBITDA (p.s.) 2.18692e+008
Qtrly Earnings Growth -1
Operating Cash Flow 0 (M)
Levered Free Cash Flow -21 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 639
Price to Book value 0
Price to Sales -1.84
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 4.29e+006
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.